ProCE Banner Activity

Individualizing CLL Therapy: Second-Line Treatment and Beyond

Slideset

In these downloadable slides, experts discuss data driving treatment decisions for patients with relapsed/refractory chronic lymphocytic leukemia.

Released: September 13, 2024

Expiration: September 12, 2025

Share

Provided by

Provided by Clinical Care Options, LLC in partnership with CLL Society

ProCE Banner

Supporters

Supported by educational grants from AbbVie Inc.; AstraZeneca; Beigene, Ltd.; and Bristol Myers Squibb.

AbbVie Inc.

AstraZeneca

BeiGene, Ltd.

Bristol Myers Squibb

Partners

CLL Society

ProCE Banner